Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012205 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Weihao Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, California, United States of America. Hauptthemen laut MEDLINE: Lysosomes, Mycobacterium tuberculosis, Monocytes, Macrophages, Alveolar. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Mycobacterium tuberculosis (Mtb) infects lung myeloid cells, but the specific Mtb-permissive cells and host mechanisms supporting Mtb persistence during chronic infection are incompletely characterized. We report that after the development of T cell responses, CD11c lo monocyte-derived cells harbor more live Mtb than alveolar macrophages (AM), neutrophils, and CD11c hi monocyte-derived cells. Transcriptomic and functional studies revealed that the lysosome pathway is underexpressed in this highly permissive subset, characterized by less lysosome content, acidification, and proteolytic activity than AM, along with less nuclear TFEB, a regulator of lysosome biogenesis. Mtb infection does not drive lysosome deficiency in CD11c lo monocyte-derived cells but promotes recruitment of monocytes that develop into permissive lung cells, mediated by the Mtb ESX-1 secretion system. The c-Abl tyrosine kinase inhibitor nilotinib activates TFEB and enhances lysosome functions of macrophages in vitro and in vivo, improving control of Mtb infection. Our results suggest that Mtb exploits lysosome-poor lung cells for persistence and targeting lysosome biogenesis is a potential host-directed therapy for tuberculosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, California, United States of America.
- Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States of America.
ORCID-Profile: Joel D Ernst
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Zheng, W., Chang, I. C., Limberis, J., Budzik, J. M., Zha, B. S., Howard, Z., Chen, L., & Ernst, J. D. (2024). Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012205
Vancouver
Zheng W, Chang IC, Limberis J, Budzik JM, Zha BS, Howard Z, et al. Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012205
BibTeX
@article{Zheng2024,
author = {Zheng, Weihao and Chang, I-Chang and Limberis, Jason and Budzik, Jonathan M and Zha, Beth Shoshana and Howard, Zachary and Chen, Lucas and Ernst, Joel D},
title = {Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012205}
}
EUVIMED